Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Membrane proteins are the gateway to cells and are involved in many critical functions. Each membrane protein is unique, and their complexity makes it difficult to fit into a standardized expression ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

Protein samples are essential to advance our understanding of disease pathways and develop new therapeutics. High-quality filtration is needed to protect purity, yield and functionality of target ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...

What’s new in the biotech world? In this listicle, we highlight recent product launches, partnerships and company events ranging in topic from efficient nucleic acid purification and PCR for beverage ...

A biotech which seeks to accelerate drug discovery by providing easy access to functional proteins through its proprietary platform has extended its total Series C funding to £64.5m.

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...